Clinical Trials Directory

Trials / Terminated

TerminatedNCT00779844

Anesthesic Propofol and Remifentanil Requirements in Obese Patients

Intravenous Anesthesia in Obese Patients: Propofol and Remifentanil Requirements

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Hopital Foch · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pharmacokinetic models for anesthetic agents are questionable. The objective of the study is to compare the propofol and remifentanil doses required to maintain the bispectral index in the range 40-60 in two groups of patients: obese patients and lean patients

Conditions

Interventions

TypeNameDescription
PROCEDUREbariatric coelioscopic surgical proceduretotal intra-venous anesthesia (propofol and remifentanil) being delivered using a close-loop system with the Bispectral Index as the single input for the controller
PROCEDUREsupra-umbilical coelioscopic surgical proceduretotal intra-venous anesthesia (propofol and remifentanil) being delivered using a closed-loop system with the Bispectral Index as the single input for the controller

Timeline

Start date
2008-12-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2008-10-24
Last updated
2016-09-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00779844. Inclusion in this directory is not an endorsement.